TGFB1 and breast carcinoma: Inhibition of TGF-β by COX has previously been reported in other organ systems [73] and loss of TGF-β ligand-mediated inhibition of mammary epithelial cell proliferation is proposed as a potential mechanism for density-associated breast cancer risk.